Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study

Masaki Shiota

doi:10.1111/iju.14864

Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study

Urology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	478-479
Number of pages	2
Journal	International Journal of Urology
Volume	29
Issue number	5
DOIs	https://doi.org/10.1111/iju.14864
Publication status	Published - May 2022

All Science Journal Classification (ASJC) codes

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/iju.14864

Cite this

@article{ce84a2125b49444c999cb7c10f07f2ea,

title = "Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study",

author = "Masaki Shiota",

note = "Funding Information: Masaki Shiota received honoraria from Janssen Pharma, AstraZeneca, and Astellas Pharma and research funding support from Daiichi Sankyo.",

year = "2022",

month = may,

doi = "10.1111/iju.14864",

language = "English",

volume = "29",

pages = "478--479",

journal = "International Journal of Urology",

issn = "0919-8172",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer

T2 - A multicenter retrospective study

AU - Shiota, Masaki

N1 - Funding Information: Masaki Shiota received honoraria from Janssen Pharma, AstraZeneca, and Astellas Pharma and research funding support from Daiichi Sankyo.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85126276224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126276224&partnerID=8YFLogxK

U2 - 10.1111/iju.14864

DO - 10.1111/iju.14864

M3 - Comment/debate

C2 - 35297110

AN - SCOPUS:85126276224

SN - 0919-8172

VL - 29

SP - 478

EP - 479

JO - International Journal of Urology

JF - International Journal of Urology

IS - 5

ER -

Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this